Free shipping on all orders over $ 500

B-Raf inhibitor 1

Cat. No. M9492

All AbMole products are for research use only, cannot be used for human consumption.

B-Raf inhibitor 1 Structure
Synonym:

ABM-0403

Size Price Availability Quantity
5mg USD 90  USD90 In stock
10mg USD 140  USD140 In stock
50mg USD 410  USD410 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

B-Raf inhibitor 1 is a potent and selective B-Raf inhibitor with cell IC50s of 0.31 µM and 2 nM for A375 proliferation and A375 p-ERK, respectively. B-Raf inhibitor 1 inhibits A375 and HCT-116 proliferation with IC50s of 0.31 and 0.72 μM, respectively. B-Raf inhibitor 1 additionally exhibits low micromolar inhibition against wild type B-Raf cell lines, which may be due to off-target kinase activities or alternatively to pan-Raf inhibition, including Raf dimers.

Chemical Information
Molecular Weight 478.94
Formula C26H19ClN8
CAS Number 1093100-40-3
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shanique Alabi, et al. Mutant-selective degradation by BRAF-targeting PROTACs

[2] Arunkumar Babu, et al. A Fluoro Derivative of Embelin, as Potent B-RAF Inhibitor in Melanoma

[3] Eunyoung Park, et al. Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes

[4] E M L Heath, et al. B-RAF: A contributor to the melanoma phenotype

[5] Gideon Bollag, et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Related Raf Products
Sorafenib-d3

Sorafenib-d3 (Donafenib) is a deuterium-labeled Sorafenib, it is the first deuterium-generation tumor suppressor small molecule. Sorafenib is a multikinase inhibitor IC50s of 6 nM, 20 nM, and 22 nM for Raf-1, B-Raf, and VEGFR-3, respectively.

XL-281

XL-281 (BMS-908662) is an orally active inhibitor for RAF kinase, with IC50s of 2.6, 4.5 and 6 nM, for CRAF, B-RAF, and B-RAFV600E, respectively.

B-Raf IN 2 

B-Raf IN 2 is a potent and selective BRAF inhibitor.

Brimarafenibum

Brimarafenibum (Brimarafenib) is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor, wtih antineoplastic effect.

Belvarafenib TFA

Belvarafenib TFA (HM95573 TFA) is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: B-Raf inhibitor 1, ABM-0403 supplier, Raf, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.